- ROUNDTABLE: Pharmacy’s future in sync with technology
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- NACDS RxImpact shines spotlight on pharmacists' increasing role in delivery of healthcare services
- EXPERT BLOG: Provider status for pharmacists — one way or another
- Study from NCPA sheds new light on med synchronization programs
OMAHA, Neb. — Amid rapid growth over the last few years, Amber Pharmacy is more than doubling the size of its headquarters.
The specialty pharmacy company announced that it would stage a grand opening of the newly expanded headquarters on June 19. Originally situated on a two-acre campus at 10004 South 152nd St. in Omaha, Neb., the company acquired an adjoining two acres and built a new building, joining it to the original via a connecting hallway with photos showcasing the company's history, adding 40,000 sq. ft. for a total of nearly 70,000, president Michael Agostino told Drug Store News, saying that the company grew by 55% last year and is trending at more than 30% this year.
"We just sort of saw what was in the pipeline coming up, and we decided it was time to grow," Agostino said.
The expanded headquarters will also house Hy-Vee Pharmacy Solutions, the company's specialty pharmacy venture with West Des Moines, Iowa-based supermarket chain Hy-Vee. The partnership has grown significantly since its launch three years ago, with Hy-Vee Pharmacy Solutions becoming the preferred specialty pharmacy for Wellmark Blue Cross Blue Shield of Iowa in October 2011.
Agostino touted the convenience of the model, saying it had grown in popularity with working-class patients. "They're picking up sundries, milk and produce, and their average-$3,000 prescription is waiting for them in the pharmacy, and they can just pick it up on the way home," he said, adding that the partnership with Wellmark had allowed Hy-Vee Pharmacy Solutions to maintain relationships between pharmacists and their patients.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.